Literature DB >> 17122009

Outbreaks of multidrug-resistant Pseudomonas aeruginosa in community hospitals in Japan.

Jun-Ichiro Sekiguchi1, Tsukasa Asagi, Tohru Miyoshi-Akiyama, Atsushi Kasai, Yukie Mizuguchi, Minako Araake, Tomoko Fujino, Hideko Kikuchi, Satoru Sasaki, Hajime Watari, Tadashi Kojima, Hiroshi Miki, Keiji Kanemitsu, Hiroyuki Kunishima, Yoshihiro Kikuchi, Mitsuo Kaku, Hiroshi Yoshikura, Tadatoshi Kuratsuji, Teruo Kirikae.   

Abstract

We previously reported an outbreak in a neurosurgery ward of catheter-associated urinary tract infection with multidrug-resistant (MDR) Pseudomonas aeruginosa strain IMCJ2.S1, carrying the 6'-N-aminoglycoside acetyltransferase gene [aac(6')-Iae]. For further epidemiologic studies, 214 clinical isolates of MDR P. aeruginosa showing resistance to imipenem (MIC >or= 16 microg/ml), amikacin (MIC >or= 64 microg/ml), and ciprofloxacin (MIC >or= 4 microg/ml) were collected from 13 hospitals in the same prefecture in Japan. We also collected 70 clinical isolates of P. aeruginosa that were sensitive to one or more of these antibiotics and compared their characteristics with those of the MDR P. aeruginosa isolates. Of the 214 MDR P. aeruginosa isolates, 212 (99%) were serotype O11. We developed a loop-mediated isothermal amplification (LAMP) assay and a slide agglutination test for detection of the aac(6')-Iae gene and the AAC(6')-Iae protein, respectively. Of the 212 MDR P. aeruginosa isolates, 212 (100%) and 207 (98%) were positive in the LAMP assay and in the agglutination test, respectively. Mutations of gyrA and parC genes resulting in amino acid substitutions were detected in 213 of the 214 MDR P. aeruginosa isolates (99%). Of the 214 MDR P. aeruginosa isolates, 212 showed pulsed-field gel electrophoresis patterns with >or=70% similarity to that of IMCJ2.S1 and 83 showed a pattern identical to that of IMCJ2.S1, indicating that clonal expansion of MDR P. aeruginosa occurred in community hospitals in this area. The methods developed in this study to detect aac(6')-Iae were rapid and effective in diagnosing infections caused by various MDR P. aeruginosa clones.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17122009      PMCID: PMC1829129          DOI: 10.1128/JCM.01772-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  51 in total

1.  Loop-mediated isothermal amplification of DNA.

Authors:  T Notomi; H Okayama; H Masubuchi; T Yonekawa; K Watanabe; N Amino; T Hase
Journal:  Nucleic Acids Res       Date:  2000-06-15       Impact factor: 16.971

2.  Convenient test for screening metallo-beta-lactamase-producing gram-negative bacteria by using thiol compounds.

Authors:  Y Arakawa; N Shibata; K Shibayama; H Kurokawa; T Yagi; H Fujiwara; M Goto
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

3.  Designation of the thirteen O-group antigens of Pseudomonas aeruginosa; an amendment for the tentative proposal in 1976.

Authors:  J Y Homma
Journal:  Jpn J Exp Med       Date:  1982-12

4.  Definition of the attI1 site of class 1 integrons.

Authors:  S R Partridge; G D Recchia; C Scaramuzzi; C M Collis; H W Stokes; R M Hall
Journal:  Microbiology       Date:  2000-11       Impact factor: 2.777

5.  Loop-mediated isothermal amplification for direct detection of Mycobacterium tuberculosis complex, M. avium, and M. intracellulare in sputum samples.

Authors:  Tomotada Iwamoto; Toshiaki Sonobe; Kozaburo Hayashi
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

6.  PCR typing of genetic determinants for metallo-beta-lactamases and integrases carried by gram-negative bacteria isolated in Japan, with focus on the class 3 integron.

Authors:  Naohiro Shibata; Yohei Doi; Kunikazu Yamane; Tetsuya Yagi; Hiroshi Kurokawa; Keigo Shibayama; Haru Kato; Kumiko Kai; Yoshichika Arakawa
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

Review 7.  Infection control in cystic fibrosis.

Authors:  Lisa Saiman; Jane Siegel
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

8.  Development and evaluation of a novel loop-mediated isothermal amplification method for rapid detection of severe acute respiratory syndrome coronavirus.

Authors:  Thi Cam Thai Hong; Quynh Le Mai; Duc Vuong Cuong; Manmohan Parida; Harumi Minekawa; Tsugunori Notomi; Futoshi Hasebe; Kouichi Morita
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

9.  Hospital outbreaks caused by Pseudomonas aeruginosa: importance of serogroup O11.

Authors:  J J Farmer; R A Weinstein; C H Zierdt; C D Brokopp
Journal:  J Clin Microbiol       Date:  1982-08       Impact factor: 5.948

10.  Detection of bacteria carrying the stx2 gene by in situ loop-mediated isothermal amplification.

Authors:  Fumito Maruyama; Takehiko Kenzaka; Nobuyasu Yamaguchi; Katsuji Tani; Masao Nasu
Journal:  Appl Environ Microbiol       Date:  2003-08       Impact factor: 4.792

View more
  30 in total

1.  Genome sequence of multidrug-resistant Pseudomonas aeruginosa NCGM1179.

Authors:  Tatsuya Tada; Tomoe Kitao; Tohru Miyoshi-Akiyama; Teruo Kirikae
Journal:  J Bacteriol       Date:  2011-11       Impact factor: 3.490

2.  Complete genome sequence of highly multidrug-resistant Pseudomonas aeruginosa NCGM2.S1, a representative strain of a cluster endemic to Japan.

Authors:  Tohru Miyoshi-Akiyama; Tomoko Kuwahara; Tatsuya Tada; Tomoe Kitao; Teruo Kirikae
Journal:  J Bacteriol       Date:  2011-12       Impact factor: 3.490

3.  A Modified Carbapenem Inactivation Method, CIMTris, for Carbapenemase Production in Acinetobacter and Pseudomonas Species.

Authors:  Kohei Uechi; Tatsuya Tada; Kayo Shimada; Kyoko Kuwahara-Arai; Momoko Arakaki; Takaaki Tome; Isamu Nakasone; Shiro Maeda; Teruo Kirikae; Jiro Fujita
Journal:  J Clin Microbiol       Date:  2017-09-27       Impact factor: 5.948

4.  IMP-43 and IMP-44 metallo-β-lactamases with increased carbapenemase activities in multidrug-resistant Pseudomonas aeruginosa.

Authors:  Tatsuya Tada; Tohru Miyoshi-Akiyama; Kayo Shimada; Masahiro Shimojima; Teruo Kirikae
Journal:  Antimicrob Agents Chemother       Date:  2013-07-08       Impact factor: 5.191

5.  Dissemination of 16S rRNA methylase ArmA-producing acinetobacter baumannii and emergence of OXA-72 carbapenemase coproducers in Japan.

Authors:  Tatsuya Tada; Tohru Miyoshi-Akiyama; Kayo Shimada; Masahiro Shimojima; Teruo Kirikae
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

6.  IMP-51, a novel IMP-type metallo-β-lactamase with increased doripenem- and meropenem-hydrolyzing activities, in a carbapenem-resistant Pseudomonas aeruginosa clinical isolate.

Authors:  Tatsuya Tada; Pham Hong Nhung; Tohru Miyoshi-Akiyama; Kayo Shimada; Doan Mai Phuong; Nguyen Quoc Anh; Norio Ohmagari; Teruo Kirikae
Journal:  Antimicrob Agents Chemother       Date:  2015-08-17       Impact factor: 5.191

7.  novel 6'-n-aminoglycoside acetyltransferase AAC(6')-Iaj from a clinical isolate of Pseudomonas aeruginosa.

Authors:  Tatsuya Tada; Tohru Miyoshi-Akiyama; Kayo Shimada; Masahiro Shimojima; Teruo Kirikae
Journal:  Antimicrob Agents Chemother       Date:  2012-10-15       Impact factor: 5.191

8.  Exit-site infection of peritoneal catheter is reduced by the use of polyhexanide. results of a prospective randomized trial.

Authors:  M Núñez-Moral; E Sánchez-Álvarez; I González-Díaz; B Peláez-Requejo; A Fernández-Viña; A Quintana-Fernández; C Rodríguez-Suárez
Journal:  Perit Dial Int       Date:  2014-02-04       Impact factor: 1.756

9.  AAC(6')-Iaf, a novel aminoglycoside 6'-N-acetyltransferase from multidrug-resistant Pseudomonas aeruginosa clinical isolates.

Authors:  Tomoe Kitao; Tohru Miyoshi-Akiyama; Teruo Kirikae
Journal:  Antimicrob Agents Chemother       Date:  2009-04-06       Impact factor: 5.191

10.  Pseudomonas aeruginosa population structure revisited.

Authors:  Jean-Paul Pirnay; Florence Bilocq; Bruno Pot; Pierre Cornelis; Martin Zizi; Johan Van Eldere; Pieter Deschaght; Mario Vaneechoutte; Serge Jennes; Tyrone Pitt; Daniel De Vos
Journal:  PLoS One       Date:  2009-11-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.